Articles
-
6 days ago |
mddionline.com | Omar Ford
Edwards Lifesciences reported new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary Resilia tissue technology have significantly improved long-term outcomes compared to those receiving non-Resilia tissue bioprosthetic valves.
-
2 weeks ago |
mddionline.com | Omar Ford
Belluscura, a maker of portable oxygen concentrators, is scrapping its 2025 guidance because of the Trump administration’s tariffs on goods imported from China. The measure caused the company’s shares to drop by 50%. Belluscura said that much of the raw materials and parts used in the portable oxygen concentrators and other devices are manufactured in China.
-
2 weeks ago |
mddionline.com | Omar Ford
Confluent Medical Technologies, a medical device and materials science contract manufacturer specializing in polymer and metal components, has reported the launch of Ultra Polyimide. This tubing material delivers nearly twice the strength of traditional polyimide. Traditional polyimide is valued for its high strength and durability, but as medical devices continue to evolve, engineers require thinner walls without sacrificing strength.
-
1 month ago |
mddionline.com | Omar Ford
Sometimes two is better than one. That’s Teleflex Medical’s current logic as the firm announced that it would split into two publicly traded companies. More specifically, the Wayne, PA-based company said that it would spin off its urology, acute care, and OEM businesses into a new publicly traded entity in 2026.
-
1 month ago |
mddionline.com | Omar Ford
Solventum is selling its purification and filtration business to Thermo Fisher Scientific for about $4.1 billion. The deal comes nearly one month after analysts found Solventum’s long-range plan lackluster. The deal is expected to close by the end of 2025. Waltham, MA-based Thermo Fisher Scientific said the purification and filtration business complemented its bioproduction unit.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 230
- Tweets
- 1K
- DMs Open
- No
FDA’s device review pipeline faces headwinds: 3,500 staff lost Longer review times expected Open communication fading Experts urge industry collaboration & global cooperation to maintain medtech innovation. https://t.co/qFapW7eeDr #MedTech #FDA #Innovation #DigitalHealth
As U.S.-China tensions rise, medtech leaders face growing challenges. How can companies stay resilient in a shifting global economy? Industry expert @scottnelsonlive shares strategies via @MDDIonline https://t.co/tOMcBs2LuU #Medtech #Geopolitics #SupplyChain #Resilience
Here's what #medtech CEOs are saying about President-Elect #Trump's #tariffs in a new article from @mddionline. https://t.co/fI1bOoFJQr